{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"29","upperLimit":"175","value":"57"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"description":"pt had MRI every 3 months","dispersionType":"95% Confidence Interval","groups":[{"description":"Rituximab administered at a dose of 375mg/m2 as a single IV infusion every week for up to 8 weeks","id":"OG000","title":"Rituximab Monotherapy"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"pt had MRI q3months","title":"Progression-free Survival","type":"SECONDARY","unitOfMeasure":"days"}